drug · small molecule
NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE
updated 6mo agoby $AMRX Amneal Pharmaceuticals, Inc.🔗 ChEMBL
community read0 votes
🐶 often sniffed alongside
top 8- tagApproval18 co-mentions · 5 sources
- drugHYDROCORTISONE16 co-mentions · 6 sources
- drugET-80016 co-mentions · 6 sources
- drugpolymyxin B6 co-mentions · 2 sources
- drugCIPROFLOXACIN HYDROCHLORIDE2 co-mentions · 1 sources
- drugciprofloxacin2 co-mentions · 1 sources
- drugciprofloxacin hydrochloride ER2 co-mentions · 1 sources
- tagSmall Molecule1 co-mentions · 1 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 35 approved and 37 investigational indications.
targets
Glucocorticoid receptor
all catalysts(0)
nothing on the calendar yet
Trials studying NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE
- phase3Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
- phase3A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- phase1Comparison of Pharmacokinetics of Infacort® Versus Immediate-release Hydrocortisone
- phase2Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH
- phase1An Investigational Study of Hydrocortisone
- phase2Lazarus: IT Therapy for ICANS
- phase1A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
- phase1A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that